Company Filing History:
5 out of 60 
3 out of 2,538 
1 out of 110 Years Active: 1997-2023
Title: Roger Schofield Newton: Innovator in Cardiovascular Treatments
Introduction
Roger Schofield Newton is a prominent inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of cardiovascular medicine, holding a total of 11 patents. His work focuses on innovative formulations and methods aimed at treating cardiovascular diseases and hypercholesterolemia.
Latest Patents
Among his latest patents are compositions that comprise fixed doses of ETC-1002 and ezetimibe. These formulations are designed to treat or reduce the risk of cardiovascular disease. Additionally, he has developed methods for using these fixed doses effectively. Another notable patent involves fixed dose combinations of ETC-1002 and one or more statins, which also target cardiovascular disease and hypercholesterolemia.
Career Highlights
Roger Newton has had a distinguished career, working with notable companies such as Esperion Therapeutics, Inc. and Warner-Lambert Company. His expertise in the pharmaceutical industry has allowed him to develop groundbreaking treatments that have the potential to improve patient outcomes significantly.
Collaborations
Throughout his career, Roger has collaborated with esteemed colleagues, including Charles Larry Bisgaier and Noah Laban Rosenberg. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Roger Schofield Newton's innovative work in cardiovascular treatments exemplifies the impact of dedicated inventors in the medical field. His contributions continue to pave the way for advancements in healthcare and patient care.